Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 83   

Articles published

ATOS 1.16 +0.01 (0.87%)
price chart
Atossa Genetics Inc. to Raise Approximately $6220000 From Institutional ...
Company Contact Steven C. Quay, M.D., Ph.D. President & Chief Executive Officer Atossa Genetics Inc. Phone: (800) 351-3902 and Kyle Guse Chief Financial Officer, General Counsel and Secretary Atossa Genetics Inc. Phone: (800) 351-3902 Investor ...
Atossa Genetics Inc (ATOS) Files Form 4 Insider Buying : H. Lawrence Remmel ...
Atossa Genetics Inc (ATOS): H. Lawrence Remmel , director of Atossa Genetics Inc purchased 5,400 shares on Jun 12, 2015.
Zacks Rating on Atossa Genetics Inc.  The Daily Rover
Atossa Genetics Inc. (ATOS) Adopts Poison Pill Provision
Atossa Genetics Inc. (Nasdaq: ATOS) announced that its Board of Directors has approved the adoption of a stockholder rights agreement.
Related articles »  
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
As a result the company improperly marketed its devices by using certain promotional claims to market the product not supported by the FDA.
Why gaining sharply? - Atossa Genetics Inc (ATOS), Penn Virginia Corporation ...  Markets Emerging
Atossa Genetics (ATOS) Gains; Henry Schein to Offer FullCYTE Breast Aspirator
Atossa Genetics Inc. (NASDAQ:ATOS) Price Target Update
Atossa Genetics Inc. (NASDAQ:ATOS): The mean estimate for the short term price target for Atossa Genetics Inc. (NASDAQ:ATOS) stands at $7.25 according to 2 Analysts.
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -1.61% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Atossa Genetics, Inc. (NASDAQ:ATOS) Has Huge Plans to Reverse the Downtrend
Atossa Genetics, Inc. (NASDAQ:ATOS, ATOS message board) stock broke the trading range on Monday as the company' recent press release announcing a new license agreement caught the attention of traders.
Atossa Genetics to Host Conference Call Today, Monday, May 18, 2015 at 4 ...  MarketWatch
Atossa Genetics Announces First Quarter 2015 Financial Results and Provides ...
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics.
Atossa Genetics' (ATOS) CEO Steven Quay on Q1 2015 Results - Earnings ...  Seeking Alpha
Atossa Genetics Inc (ATOS) Discloses Form 4 Insider Buying : H. Lawrence ...
Atossa Genetics Inc (ATOS) Discloses Insider Transaction. H. Lawrence Remmel , director of Atossa Genetics Inc purchased 5,400 shares on Jun 12, 2015.
Company Shares of Atossa Genetics Inc. Rally 4.72%  The Daily Rover
Healthcare Gainers: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), Loxo ...  Stock Transcript
Atossa Genetics Announces Issuance of Patent US9,052318 by the US Patent ...
Contact: Atossa Genetics Inc. Steven C. Quay, Ph.D., M.D. Chairman, President and CEO (O) 800-351-3902 steven.quay@atossagenetics.